2020 found the United States embroiled in a chaotic political environment, reckoning with social unrest and racial injustice, and voting in one of the most consequential presidential elections in the country’s history.
In seeking to combat emerging infectious diseases and other 21st-century health threats, the path to better prepared, protected, and healthy individuals, families, and communities could rely on unlocking the collective power of the global community. BLUE KNIGHT™ seeks to answer this call.
Approximately 300,000 children from infancy to age 14 are diagnosed with cancer worldwide every year [1]. Although cure rates for some pediatric cancers have increased to about 80% in recent [….]
U.S. Black consumers spend $1.2 trillion annually, with shoppers spending an estimated $127 million on grooming aids and $465 million on skin care. However, according to the Census Bureau only [….]
When only 1%-3% of dermatologists are Black and the five-year survival rate for a Black patient diagnosed with melanoma is only 65% versus 90% for white patients, we must ask [….]
Mental health disorders remain the highest unmet medical need, surpassing cancer. In the United States alone, more than 10 million adults indicate an unmet need in mental health treatment. Researchers [….]
Can our bodies be trained to destroy cancer cells? CAR-T therapies have undoubtedly garnered significant attention and investment over the past several years even with the risks and development challenges [….]
National Capital Consortium for Pediatric Device Innovation (NCC-PDI) Announces Virtual Pediatric Pitch Competition Winners The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) recently announced the winners of its annual [….]
4 Key Insights for Startups and Entrepreneurs Looking to Grow a Life Science Business BioHealth Capital Region Key Opinion Leaders and Connectors Share Thoughts on Growing the Region’s Innovation Ecosystem [….]
In Conversation: Sally Allain, Head, JLABS @ Washington, DC – Johnson & Johnson Innovation BioBuzz recently caught up with the Head of JLABS @ Washington, DC, Sally Allain, to discuss [….]
